Showing results (291-300 of 411) with videos related to
Sort By:
Pageof 42
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 13, 2018
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ<sub>1-42</sub>, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40Harald Hampel, Nicola Toschi, Filippo Baldacci, et al.Plos One|June 7, 2013
Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI dataMartin Dyrba, Michael Ewers, Martin Wegrzyn, et al.Journal of Alzheimer'S Disease : JAD|July 22, 2017
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional StudySimone Lista, Nicola Toschi, Filippo Baldacci, et al.Neurodegenerative Disease Management|March 30, 2023
The amyloid-β pathway in Alzheimer's disease: a plain language summaryHarald Hampel, Yan Hu, John Hardy, et al.Neurodegenerative Disease Management|July 22, 2022
The use of lumbar puncture and safety recommendations in Alzheimer's disease: a plain language summaryHarald Hampel, Aya Elhage, Leslie M Shaw, et al.Neurobiology of Aging|December 17, 2010
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performanceMichael Ewers, Cathal Walsh, John Q Trojanowski, et al.Clinical Chemistry and Laboratory Medicine|December 14, 2006
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodiesHugo Vanderstichele, Karen De Vreese, Kaj Blennow, et al.Archives of General Psychiatry|January 7, 2004
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid studyHarald Hampel, Katharina Buerger, Raymond Zinkowski, et al.Med (New York, N.Y.)|May 10, 2025
The impact of real-world evidence in implementing and optimizing Alzheimer's disease careHarald Hampel, Gang Li, Michelle M Mielke, et al.Aging Clinical and Experimental Research|November 22, 2019
Randomized controlled trial on the efficacy of a multilevel non-pharmacologic intervention in older adults with subjective memory decline: design and baseline findings of the E.Mu.N.I. studyElena Rolandi, Alessandra Dodich, Samantha Galluzzi, et al.Pageof 42